For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Dexcom's Apple Watch app will be ready to go when the device launches in April, the company told the Wall Street Journal. The app, which will not need to seek pre-market approval from the FDA thanks ...

DexCom Inc. DXCM shares were mostly flat in Thursday's extended trading after the company released its fourth-quarter earnings report. Here's a look at the details in the report. Watch the price DXCM ...

Shares of DexCom Inc. DXCM shed 2.85% to $68.16 Tuesday, on what proved to be an all-around mixed trading session for the ...

At long last, Dexcom's Share app, which allows users to view and share data from their G5 continuous glucose monitors, will be available for Android users. The Android app just now received FDA ...

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings this Thursday after market hours. Here’s what you need ...

DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...

Dexcom (NSDQ:DXCM) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus forecast.

DexCom, Inc.’s (NASDAQ:DXCM) third-quarter 2025 revenue reached $1.209 billion, beating the analyst consensus estimate of $1.179 billion. Revenue grew 22% year-over-year on a reported basis and 20% ...

Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit. The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months ...